Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 14 studies | 54% ± 18% | |
endothelial cell | 11 studies | 33% ± 9% | |
macrophage | 3 studies | 55% ± 22% | |
endothelial cell of vascular tree | 3 studies | 28% ± 10% | |
ependymal cell | 3 studies | 40% ± 21% |
Insufficient scRNA-seq data for expression of SLC7A11 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 2917.07 | 2619 / 2642 | 99% | 24.73 | 699 / 705 |
pancreas | 87% | 550.90 | 284 / 328 | 55% | 4.88 | 98 / 178 |
lung | 69% | 787.32 | 398 / 578 | 70% | 21.66 | 813 / 1155 |
stomach | 59% | 1150.51 | 211 / 359 | 72% | 8.22 | 207 / 286 |
esophagus | 32% | 418.68 | 464 / 1445 | 91% | 34.21 | 166 / 183 |
bladder | 62% | 670.57 | 13 / 21 | 44% | 11.87 | 224 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.88 | 1 / 1 |
thymus | 67% | 983.23 | 439 / 653 | 32% | 2.65 | 191 / 605 |
intestine | 13% | 95.97 | 130 / 966 | 79% | 9.21 | 414 / 527 |
skin | 49% | 1279.90 | 889 / 1809 | 33% | 5.11 | 157 / 472 |
prostate | 23% | 130.88 | 56 / 245 | 58% | 3.84 | 291 / 502 |
ovary | 24% | 163.44 | 43 / 180 | 50% | 4.46 | 216 / 430 |
uterus | 8% | 87.89 | 13 / 170 | 38% | 6.35 | 173 / 459 |
breast | 12% | 72.22 | 57 / 459 | 30% | 3.02 | 340 / 1118 |
tonsil | 0% | 0 | 0 / 0 | 38% | 4.25 | 17 / 45 |
heart | 37% | 303.01 | 319 / 861 | 0% | 0 | 0 / 0 |
liver | 6% | 34.23 | 14 / 226 | 22% | 2.26 | 91 / 406 |
lymph node | 0% | 0 | 0 / 0 | 24% | 1.36 | 7 / 29 |
peripheral blood | 20% | 468.87 | 185 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 15% | 87.84 | 203 / 1335 | 0% | 0 | 0 / 0 |
kidney | 2% | 9.16 | 2 / 89 | 10% | 1.08 | 87 / 901 |
adrenal gland | 5% | 61.95 | 12 / 258 | 6% | 0.31 | 13 / 230 |
spleen | 5% | 19.15 | 12 / 241 | 0% | 0 | 0 / 0 |
adipose | 5% | 30.45 | 57 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.72 | 2 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050804 | Biological process | modulation of chemical synaptic transmission |
GO_0034775 | Biological process | glutathione transmembrane transport |
GO_0070527 | Biological process | platelet aggregation |
GO_0090461 | Biological process | intracellular glutamate homeostasis |
GO_0015813 | Biological process | L-glutamate transmembrane transport |
GO_0060173 | Biological process | limb development |
GO_0110076 | Biological process | negative regulation of ferroptosis |
GO_0098712 | Biological process | L-glutamate import across plasma membrane |
GO_0014070 | Biological process | response to organic cyclic compound |
GO_0021756 | Biological process | striatum development |
GO_0051223 | Biological process | regulation of protein transport |
GO_0008542 | Biological process | visual learning |
GO_1903786 | Biological process | regulation of glutathione biosynthetic process |
GO_0050807 | Biological process | regulation of synapse organization |
GO_0021591 | Biological process | ventricular system development |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0048021 | Biological process | regulation of melanin biosynthetic process |
GO_0051775 | Biological process | response to redox state |
GO_1901494 | Biological process | regulation of cysteine metabolic process |
GO_0035094 | Biological process | response to nicotine |
GO_0140924 | Biological process | L-kynurenine transmembrane transport |
GO_0003333 | Biological process | amino acid transmembrane transport |
GO_1900407 | Biological process | regulation of cellular response to oxidative stress |
GO_0030534 | Biological process | adult behavior |
GO_2000211 | Biological process | regulation of glutamate metabolic process |
GO_0015811 | Biological process | L-cystine transport |
GO_0140206 | Biological process | dipeptide import across plasma membrane |
GO_0009636 | Biological process | response to toxic substance |
GO_0070306 | Biological process | lens fiber cell differentiation |
GO_1904717 | Biological process | regulation of AMPA glutamate receptor clustering |
GO_0033029 | Biological process | regulation of neutrophil apoptotic process |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0006749 | Biological process | glutathione metabolic process |
GO_0048286 | Biological process | lung alveolus development |
GO_0031526 | Cellular component | brush border membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0031528 | Cellular component | microvillus membrane |
GO_0009986 | Cellular component | cell surface |
GO_0097449 | Cellular component | astrocyte projection |
GO_0045177 | Cellular component | apical part of cell |
GO_0015179 | Molecular function | L-amino acid transmembrane transporter activity |
GO_0140926 | Molecular function | L-kynurenine transmembrane transporter activity |
GO_0015327 | Molecular function | cystine:glutamate antiporter activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SLC7A11 |
Protein name | Basigin Uncharacterized protein SLC7A11 Cystine/glutamate transporter (Amino acid transport system xc-) (Calcium channel blocker resistance protein CCBR1) (Solute carrier family 7 member 11) (xCT) Solute carrier family 7 member 11 |
Synonyms | |
Description | FUNCTION: Heterodimer with SLC3A2, that functions as an antiporter by mediating the exchange of extracellular anionic L-cystine and intracellular L-glutamate across the cellular plasma membrane . Provides L-cystine for the maintenance of the redox balance between extracellular L-cystine and L-cysteine and for the maintenance of the intracellular levels of glutathione that is essential for cells protection from oxidative stress (By similarity). The transport is sodium-independent, electroneutral with a stoichiometry of 1:1, and is drove by the high intracellular concentration of L-glutamate and the intracellular reduction of L-cystine . In addition, mediates the import of L-kynurenine leading to anti-ferroptotic signaling propagation required to maintain L-cystine and glutathione homeostasis . Moreover, mediates N-acetyl-L-cysteine uptake into the placenta leading to subsequently down-regulation of pathways associated with oxidative stress, inflammation and apoptosis . In vitro can also transport L-aspartate . May participate in astrocyte and meningeal cell proliferation during development and can provide neuroprotection by promoting glutathione synthesis and delivery from non-neuronal cells such as astrocytes and meningeal cells to immature neurons (By similarity). Controls the production of pheomelanin pigment directly (By similarity). . |
Accessions | ENST00000280612.9 A0A346RDT0 A0A346RDX9 A0A346RCR1 A0A346RDX8 A0A346RDY0 A0A346RDU2 A0A346REH8 Q4W5A5 ENST00000509248.1 Q9UPY5 A0A346REM6 H0Y9F9 A0A346RDX7 A0A346RCP0 |